Rumbaoa, Reynie P.
HRN: 22-28-23 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/02/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/02/2022
12/12/2022
IVT
4.5g
Q12
T/c Sepsis. Severe Anemia Sec To UGIB Sec To NSAID Use
Waiting Final Action
Indication: Empirical Escalation Type of Infection: BloodstreamIntra-abdominalUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes